Cargando…

PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer

Detalles Bibliográficos
Autor principal: Liang, Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196060/
https://www.ncbi.nlm.nih.gov/pubmed/35676753
http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0244
_version_ 1784727104247562240
author Liang, Han
author_facet Liang, Han
author_sort Liang, Han
collection PubMed
description
format Online
Article
Text
id pubmed-9196060
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Compuscript
record_format MEDLINE/PubMed
spelling pubmed-91960602022-06-24 PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer Liang, Han Cancer Biol Med Editorial Compuscript 2022-05-15 2022-06-09 /pmc/articles/PMC9196060/ /pubmed/35676753 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0244 Text en Copyright: © 2022, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0 (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial
Liang, Han
PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer
title PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer
title_full PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer
title_fullStr PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer
title_full_unstemmed PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer
title_short PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer
title_sort pd-1 inhibitors provide new opportunities in conversion therapy for stage iv gastric cancer
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196060/
https://www.ncbi.nlm.nih.gov/pubmed/35676753
http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0244
work_keys_str_mv AT lianghan pd1inhibitorsprovidenewopportunitiesinconversiontherapyforstageivgastriccancer